Navigation Links
Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
Date:5/11/2009

in the future."

Top Line Study Results

Logical also announced the reporting of data from its double-blind, randomized, active comparator study of LT-NS001 vs. naproxen, in subjects 45 to 70 years of age. LT-NS001 is a novel, patented NCE pro-drug of the popular non-steroidal anti-inflammatory drug (NSAID) naproxen, which is being developed to significantly reduce the GI safety risks, including the formation of ulcers, associated with naproxen.

In the study, subjects underwent upper endoscopies at baseline and on day seven. Subjects receiving LT-NS001 experienced statistically significantly fewer endoscopically confirmed gastric ulcers compared to subjects receiving naproxen. The full results from this study will be presented at scientific meeting during the third quarter of 2009. See below for additional information on LT-NS001.

Financing Milestone Achieved

As a result of completing this proof-of-concept study demonstrating the improved GI safety of LT-NS001 in humans, Logical Therapeutics has successfully completed all of the milestones associated with its Series B financing round. Logical intends to continue to progress the clinical development of LT-NS001, as well as its other programs, to fully explore their commercial potential as candidates for partnering.

About LT-NS001

LT-NS001 is a novel, patented NCE pro-drug of the popular non-steroidal anti-inflammatory drug (NSAID) naproxen, which is being developed by Logical Therapeutics to significantly decrease the GI safety risks associated with naproxen. Naproxen is widely regarded as the NSAID with the most favorable cardiovascular safety profile among all of the drugs in this class.

LT-NS001 is pharmacologically inactive as an NSAID in the GI tract, but once absorbed into the bloodstream, it is converted rapidly and quantitatively to naproxen. It
'/>"/>

SOURCE Logical Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
2. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
3. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
4. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
5. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
6. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
7. Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
8. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
9. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
10. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
11. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ire/--LigonDiscovery,Inc.,whichusesproprietarysmal...h-valuetargets,todayannouncedtheappointmentofpharm...cutiveChairmanoftheBoard. ,, "I,mverypleasedtow...aidPatrickKleyn,Ligon,schiefexecutiveofficerandco-...fesciencesindustry--particularlyhisleadershiptakin...
(Date:11/23/2009)...portlinker.comannouncesthatanewmarketresearchrepor...CSandEMR ,, http://www.reportlinker.com/p016...newswire&utm_medium=pr&utm_campaign=prnews...lmost$1.3billion,representinganincreaseof6.7%over2...mediumhospitals(201-499beds),communityhospitals(20...
(Date:11/23/2009)...portlinker.comannouncesthatanewmarketresearchrepor...stems&Equipment-AGlobalMarketPerspective ,...tion-Systems--Equipment---A-Global-Market-Perspect...mp;utm_campaign=prnewswire ,, Steamsteriliz...cedure.Steamsterilizationmarketisstableduetoregula...
Breaking Medicine Technology:Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman 2Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7Genstar Capital Portfolio Company Univita Health Completes Debt Financing 52417 1Genstar Capital Portfolio Company Univita Health Completes Debt Financing 52417 2Genstar Capital Portfolio Company Univita Health Completes Debt Financing 52417 3Life Sciences 26 Health Care Companies Unprepared for Information Security Risks 3A Deloitte Survey 52415 1Life Sciences 26 Health Care Companies Unprepared for Information Security Risks 3A Deloitte Survey 52415 2Life Sciences 26 Health Care Companies Unprepared for Information Security Risks 3A Deloitte Survey 52415 3Life Sciences 26 Health Care Companies Unprepared for Information Security Risks 3A Deloitte Survey 52415 4Aflac Incorporated To Release Second Quarter Results on July 29 2009 52413 1Aflac Incorporated To Release Second Quarter Results on July 29 2009 52413 2
... 2007 /PRNewswire-USNewswire/ -- Magnetic,Resonanc...with,cancer in one breast detected over 90 percent...y mammography and clinical breast,exam at initial ...ablished rates of mammography and clinical breast ...tralateral breast, adding,an MRI scan to the diagn...
... Soy Nuts May Reduce Inflammation After,Menopause;...Reduces,Insulin Resistance, ALEXANDRIA, Va., March...iabetes are more likely to develop Parkinson,s dis... what accounts for the,link between the two diseas...e April issue of Diabetes Care. , The study, by re...
Other Medicine Technology:MRI Detects Cancers in the Opposite Breast of Women Newly Diagnosed,with Breast Cancer 2MRI Detects Cancers in the Opposite Breast of Women Newly Diagnosed,with Breast Cancer 3MRI Detects Cancers in the Opposite Breast of Women Newly Diagnosed,with Breast Cancer 4Diabetes Linked to Higher Parkinson's Risk 2Diabetes Linked to Higher Parkinson's Risk 3Diabetes Linked to Higher Parkinson's Risk 4
(Date:11/24/2009)...t least one child were less likely to become disab...HealthDay News) -- Having children may slow the pr...ests. , Belgian researchers followed 330 women...en the ages of 22 and 38. , Women who had given...likely to have the disease progress to a stage in ...
(Date:11/24/2009)...ov.24/PRNewswire-Asia/--SundiaMediTechCompany,alea...yinChina,isproudtoannounce,thatthecompanyreceivedt...dgiventothetop100privatetechnologycompaniesintheAs...ologyFast100listeveryyearforvarious,regions,suchas...technologycompanieswhichmeettherequirementsofcutti...
(Date:11/24/2009)...srael,November24/PRNewswire-FirstCall/--ICL(TASE:I...company,todayreported,resultsforthethirdquarterand...esultsfortheThirdQuarter , Revenues:Revenuesf...omparedsequentiallywith$1,083millionforthesecondqu...2,178million,reflecting,theexceptionaldemandandpri...
(Date:11/24/2009)... Along with his state-of-the-art website, D...edia to interact with patients and share informati...tice and the procedures that he offers. , ..., 2009 -- North Carolina plastic surgeon Dr. Ric...king site Facebook to expand his reach and keep an...
(Date:11/24/2009)... Dr. Tom Lintner is embracing the latest to...nd keep an ongoing dialogue with patients. Through..., Dr. Lintner provides information about his Atla...any questions that patients may have. , ...09 -- A plastic surgeon in Atlanta is taking ful...
Breaking Medicine News(10 mins):Health News:Childbirth May Slow Progression of Multiple Sclerosis 2Health News:Childbirth May Slow Progression of Multiple Sclerosis 3Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 2Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 3Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 4Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 5Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 6Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 7Health News:North Carolina Plastic Surgeon Embracing Social Media to Connect with Patients and Reach Out to Community 2Health News:North Carolina Plastic Surgeon Embracing Social Media to Connect with Patients and Reach Out to Community 3Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 2Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 3
...n Dental Institute along with the Hong Kong Cleft ... will provide free treatment for congenital facial...was inaugurated on 6 December 2005 by Professor N....ed up with Hong Kong's Prince Philip Dental Hospit...
...has found that even after issuing proper guideline...ss to the correct treatment measures more specific...nd that this treatment regimen boosts the chances ... are given chemotherapy in addition to surgery. Th...
... refused help, say paramedics The disabled, ...ncouver over the weekend// in sub-zero temperature...s. According to BC ambulance Service sources...tance from the paramedics, they said. Eight ...
...e residents are recovering from the earlier spell ...0 valuable human lives, another report of causalit...reports, the patient (32-year-old male) was admitt...llo Hospital, where he died. The health offi...
...acement therapy could be the answer to prevent hea... Kaplan, from Wake Forest University Baptist Medic... and even HRT is generally frowned upon since it s.... It is a generally known fact that women are able...
...ort submitted recently regarding the impact of med...t teenagers are vulnerable to smoke after visualiz...evisions. It is also in favor of exclusion of smok...abit during adolescence. "The weight of doze...
Other Medicine News:Health News:Meningitis is rocking the capital again 2Health News:Smoking Related Scenes in Movies Increase Teenage Susceptibility To Smoke 2
...sfer an Entire Column of a 384 Well Plate at Once ...well plates, you need a pipettor that can adapt to...et with our 16-channel Impact pipettor., Availabl...ct2), this innovation was specifically designed to...
EnTrust Dual Chamber ICD
Alliance™ Catheter Delivery System Introducers
...onic has been a key participant in the area of blo...vious Medtronic autotransfusion systems allowed cl...d platelets, as well as to determine requirements ...-rich plasma (PRP) for a small amount of autologou...
Medicine Products: